This New Statesman podcast episode has been fully funded by argenx and features an edited panel discussion recorded at the New Statesman’s Igniting Growth Conference.
The UK has world-leading science, research and regulatory expertise, but too often struggles to turn those strengths into investment, innovation and better patient access.